This book looks at "...the recent history and the many struggles related to advocacy for access to [antiretroviral] medicines of engaged civil society. Through the experiences of five middle-income countries - Brazil, China, Colombia, India, and Thailand." It presents "...the perspective of local civil society organisations about the national impact of intellectual property protection and access to medications. "These five countries were chosen due to their accumulated experience in this field, their capacity to produce generic medication, their activist efforts, and the exchange of ideas and information that already exists between them"
In this recording Dr Suwit Wibulpolprasert of the Thai Ministry of Public Health talks about Thailand's experience when it issued compulsory licenses for two antiretroviral medicines in order to be able to treat more patients. Despite being put on a 'trade black list' by the US Government, the move was a success in public health terms, enabling the Thai Government to purchase more medicines and dramatically increase the availability of treatment for people living with AIDS
Documents MSF's experience of purchasing anti-retroviral drugs in ten low and middle income countries. The report looks at ARV selection, pricing and procurement issues. It highlights five issues: sources (quality), registration, prices, patents, and the continous availability of medicines
Source e-bulletin on Disability and Inclusion